Pegylated growth hormone releasing factor (Serono)

聚乙二醇化生长激素释放因子

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegylated growth hormone releasing factor (Serono)
Drug Alias NamePegylated growth hormone releasing factor - SeronoPEG-GHRF
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionGrowth hormone releasing factor agonists
TargetsGrowth hormone releasing factor
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono
Active IndicationsN/A
Inactive IndicationsGrowth hormone deficiency

Other Information

ATC CodeN/A
Related LinksN/A